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Abstract
Background: MicroRNAs are ~22-nt long regulatory RNAs that serve as critical modulators of post-transcriptional
gene regulation. The diversity of miRNAs in endothelial cells (ECs) and the relationship of this diversity to epithelial
and hematologic cells is unknown. We investigated the baseline miRNA signature of human ECs cultured from the
aorta (HAEC), coronary artery (HCEC), umbilical vein (HUVEC), pulmonary artery (HPAEC), pulmonary
microvasculature (HPMVEC), dermal microvasculature (HDMVEC), and brain microvasculature (HBMVEC) to
understand the diversity of miRNA expression in ECs.
Results: We identified 166 expressed miRNAs, of which 3 miRNAs (miR-99b, miR-20b and let-7b) differed
significantly between EC types and predicted EC clustering. We confirmed the significance of these miRNAs by RT-
PCR analysis and in a second data set by Sylamer analysis. We found wide diversity of miRNAs between
endothelial, epithelial and hematologic cells with 99 miRNAs shared across cell types and 31 miRNAs unique to
ECs. We show polycistronic miRNA chromosomal clusters have common expression levels within a given cell type.
Conclusions: EC miRNA expression levels are generally consistent across EC types. Three microRNAs were variable
within the dataset indicating potential regulatory changes that could impact on EC phenotypic differences. MiRNA
expression in endothelial, epithelial and hematologic cells differentiate these cell types. This data establishes a
valuable resource characterizing the diverse miRNA signature of ECs.
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Background
MicroRNAs (miRNAs) are highly conserved ~22 nt long
regulatory RNAs. Critical modulators of post-transcrip-
tional gene regulation, miRNAs bind to 3’ UTR regions of
mRNAs, where they function to block translation and
decrease mRNA stability. To date, over 800 miRNAs have
been identified in the mammalian genome. The diversity
of these miRNAs and the regulatory roles they have in dif-
ferent cell types are just beginning to be explored.
Hundreds of studies have been performed investigat-
ing miRNA expression differences by array, deep RNA
sequencing or qRT-PCR methods. Generally these stu-
dies either compare normal tissue to a diseased/malig-
nant/perturbed state or developmental tissues over a
time course [1-3]. There are fewer studies investigating
miRNA expression patterns in normal tissues. A
pioneering experiment investigated miRNAs from the
heart, liver, spleen, small intestine, colon and brain of
mice, identifying several “organ specific” miRNAs [4]. A
second study of 24 human organs confirmed and
expanded on these initial findings. It also demonstrated
that miRNA expression was highly correlated to other
miRNAs located within 50-kb of each other suggesting
coordinated polycistronic miRNA expression in tissues
[5]. While these and other studies have demonstrated
miRNA organ specificity, they did not compare indivi-
dual cell types. Most organs are comprised of a variety
of cell types. For example, the small bowel is comprised
of multiple types of epithelial cells, endothelial cells,
smooth muscle cells, and inflammatory cells. Thus addi-
tional experiments are needed to tease apart the miRNA
contributions of these different cell types. Endothelial
cells (ECs), in particular, are located in all organs thus
their miRNA expression patterns are not accounted for
i nw h o l et i s s u ee x p e r i m e n t s . Exploring relative cell-
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regulatory control of miRNAs in different cell types.
The importance of miRNAs to endothelial cell activity
has been demonstrated. The knockdown of Dicer, a
miRNA processing enzyme, unexpectedly resulted in a
severe attenuation of angiogenesis [6]. This was an early
pivotal experiment in EC miRNA biology. A number of
miRNAs have since been described that are expressed at
high levels in the endothelium and regulate key genes and
activities. Several studies, with advancing numbers of miR-
NAs evaluated, have provided a starting point for EC
miRNA discovery [7-10]. MicroRNAs including miR-126,
miR-19a, and miR-21 modulate genes such as VCAM-1,
cyclin D1, and eNOS [6,7,11]. In turn these interactions
regulate critical pathways of angiogenesis, response to shear
stress, cellular proliferation and NO production [12-14].
While miRNAs are important in endothelial cell (EC) func-
tion, the similarity/differences of their expression patterns
across a variety of EC types has not been established.
An EC’s vascular bed of origin strongly affects its phe-
notype, gene expression, and protein expression. For
example, variable cell-cell junction activity, orientation
to flow, fenestration size, vesicle formation, and micro-
villi count are some of the molecular differences that
explain how macrovascular ECs from the aorta are
known to behave differently than microvascular ECs
taken from the liver sinusoids [15]. Recent work by Bha-
sin et al, identified unique patterns of gene expression
(mRNA) in 5 unstimulated cell cultures of ECs taken
from macrovascular, microvascular, and venous loca-
tions [16]. In this study, mRNA expression patterns
could be used to cluster EC types, differentiating micro-
vascular and macrovascular types based on shared gene
expression. Patterns of protein expression are also influ-
enced by EC origin. A proteomic comparison of bovine
aortic ECs, lymphatic ECs and venous ECs by MALDI-
TOF identified numerous variably expressed proteins
[17], again demonstrating diverse expression patterns of
ECs from different vascular beds. Differences in miRNAs
across these EC types are unknown.
Because phenotypic, genetic, and protein differences
exist between ECs taken from different vascular loca-
tions, we hypothesized that miRNAs would also vary
between these same ECs. We believed these miRNA dif-
f e r e n c e sw o u l di n f o r mu so fc l a s s e so fE C st h a tm a y
share similar regulatory mechanisms. We also sought to
compare global EC miRNA expression patterns with
cells of different lineages. This would establish patterns
of miRNA that were shared or unique to ECs.
Results
Endothelial cell miRNA diversity
Total RNA was isolated from 7 primary EC cultures
grown under identical conditions and hybridized to an
Agilent V3 miRNA array. The array contained 843
human miRNAs, allowing us to determine a deep inven-
tory of EC miRNA expression. After normalization, we
identified 164 miRNAs expressed in ECs. Of these, 59
miRNAs (40%) were statistically variable between at
least one comparison of EC types (ex. HUVEC vs
HAEC) based on LIMMA pairwise differential expres-
sion analysis with an unadjusted p-value < 0.05 (Addi-
tional file 1, Table S1). Only 3 of these 59 miRNAs, let-
7b, miR-20b and miR-99b, were also significantly differ-
e n ta c r o s sa l lE C sa sd e t e c t e db yt h eS A Ma l g o r i t h m ,
having 2.1, 1.6 and 1.8 fold variability respectively. We
used the analyses (LIMMA significant and SAM signifi-
cant) to generate both a hierarchical cluster heat map
and an unsupervised Pearson Correlation based cluster
map (Figure 1A, B). Both analyses yielded similar results.
Human umbilical vein endothelial cell (HUVEC) and
human brain microvascular endothelial cell (HBMVEC)
cultures shared a similar miRNA signature and human
coronary endothelial cells (HCECs) and human pulmon-
ary artery endothelial cells (HPAECs) shared a similar
miRNA signature. The human aortic endothelial cell
(HAEC), human pulmonary microvascular endothelial
cell (HPMVEC) and human dermal microvascular
endothelial cell (HDMVEC) cultures were a third, less
organized cluster.
RT-PCR confirmation of EC miRNA array data
As validation of the SAM significant miRNAs, we per-
formed RT-PCR for the mature miRNAs miR-99b, let-
7b and miR-20b using TaqMan assays. RT-PCR Ct
values were normalized to U6 snRNA for the mature
miRNAs (Additional file 2, Figure S1). We compared
the RT-PCR data to the pairwise comparison data in the
miRNA array data set (Additional file 1, Table S1). We
confirmed that of the 39 significantly different compari-
sons in the original data set, 27 (69%) were also signifi-
cant (p ≤ 0.05) by unadjusted t-test in our RT-PCR data
set (Additional file 1, Table S1).
MicroRNA chromosomal cluster analysis
The three SAM significant miRNAs - miR-20b, miR-99b
and let-7b - are located in miRNA clusters on chromo-
somes X, 19 and 22 respectively. We evaluated the rela-
tive expression patterns of the additional miRNAs in
these clusters to determine if our data gave a signal of
polycistronic regulation (Figure 1C). MiRNA-20b clus-
ters with miR-18b, miR-92a-2, miR-19b, miR-363, and
miR-106a. MiRNAs 18b, and 19b had expression pat-
terns similar to miR-20b. MiRNA-92a-2 data is con-
founded by its homolog (miR-92a-1) on chromosome 13
w h o s es i g n a lc a n n o tb ed i f f e r e n t i a t e db ym i R N Aa r r a y
[5]. We did not have data on miR-106a and miR-363.
Let-7a, in a cluster with let-7b, shared a common
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Page 2 of 13expression pattern as did miRNAs let-7e and miR-125a
(3p & 5p) both in a cluster with miR-99b (Figure 1C).
This data suggested that entire miRNA chromosomal
clusters are differentially regulated in ECs likely as poly-
cistronic transcripts.
As a direct measure of the regulation of a polycistro-
nic cluster, we attempted to investigate the expression
of the primary transcripts (pri-miRNAs) for the miR-
99b, let-7a (containing let-7b) and miR106a (containing
miR-20b) clusters that encode these miRNAs. The RT-
PCR primers for the miR-99b and let-7a primary tran-
scripts were designed in exons found in an NCBI RNA
r e f e r e n c es e q u e n c e( R e f s e q )g e n ep r o x i m a lt ot h e
miRNA clusters. No Refseq gene, human EST or mRNA
proximal to miR-20b is known, preventing us from
developing a suitable RT-PCR primer pair for detection
of the miR-106a cluster. We observed a similar expres-
sion pattern of pri-miRNAs transcripts (normalized to
b-actin) to the mature miRNAs let-7b and miR-99b
demonstrating that these miRNA clusters are regulated
from a common promoter region in these cell types
(Additional file 2, Figure S1).
We then investigated the miRNA profile of all chro-
mosomal clusters to determine if there were additional
polycistronic transcripts that were variably expressed
between EC lines with stronger signal than individual
miRNAs. We found 27 cross-EC comparisons, from 9
miRNA chromosomal clusters, in which overall polycis-
tronic expression was statistically different in pairwise
comparisons between EC types. After removing indivi-
dually significant miRNAs (based on LIMMA analysis -
Additional file 1, Table S1) from these 27 comparisons,
22 comparisons, in 8 unique miRNA chromosome clus-
ters remained significantly different (Table 1).
In vivo miRNA expression
We next determined if the miRNAs identified in our
expression array could also be seen in vivo.W ep e r -
formed LNA-ISH staining of miR-126, let-7b and the
control U6 snRNA. Endothelial cells were identified
with PECAM1 (CD31) immunohistochemical staining.
We identified strong endothelial staining across diverse
vascular beds for miR-126. Let-7b was weaker and more
variable in the ECs (Figure 2). Of note, miR-126 staining
was noticeably stronger in microvessels within a pul-
monary lymph node than in the adjacent lymphocytes
consistent with the expression data (Additional file 3,
Figure S2).
miRNA predictions based on Sylamer analysis
The mRNA expression patterns of five EC primary cul-
tures, grown similar to our own ECs, have been
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Figure 1 Endothelial cell miRNA clustering. (A) Hierarchical clustering based on LIMMA pairwise differential analysis of 59 miRNAs that had an
unadjusted p value < 0.05. (B) Hierarchical cluster based on the SAM significant miRNAs let-7b, miR-20b and miR-99b. (C) Heat map
demonstrating similar expression patterns across miRNAs within the same chromosomal cluster. Light blue represents low expression, dark blue
represents high expression.
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Page 3 of 13previously described and are available at Gene Expres-
sion Omnibus (GEO - GSE21212) [16]. We used this
mRNA data set to determine if we could identify a sig-
nature of miRNAs acting on mRNA expression variabil-
ity among ECs. We used the program Sylamer to
identify the representation of 3’UTR miRNA binding
sites in genes over or under expressed in a given cell
type [18]. Sylamer is a bioinformatics program that cata-
logs putative miRNA binding sites in the 3’UTR regions
of genes and determines if that pattern deviates from
neutral expectations in rank-ordered lists of genes.
We began by cataloging all miRNAs that were identi-
fied to have a significant enrichment of 3’ UTR binding
sites in genes variably expressed across any EC compari-
s o n( a tp<1 0
-4). We performed 11 analyses that com-
pared ECs of different origins (HUVEC vs HAEC,
HAEC vs HCEC, etc) for 6, 7, and 8mer bp length
miRNA binding sites. We identified 172 instances in
which any miRNA 3’UTR binding site was enriched (p
≤10
-4) across these comparisons. These 172 enrichments
were from 107 different miRNAs. Interestingly, the
SAM significant miRNAs miR-99b, miR-20b and let-7b
were identified 15 times in this group (Figure 3). We
determined how likely it was to identify the abundance
of these 3 miRNAs by chance by performing a resam-
pling analysis with 10, 000 permutations to determine
the likelihood that any combination of 3 miRNAs would
be identified 15 times (Figure 3B). No other collection
of 3 miRNAs were identified 15 times in the data set,
indicating highly significant (p < 0.0001) selection for
binding sites for miRNAs miR-99b, miR-20b and let-7b.
We then determined if this signal was biologically
relevant. For each comparison of two EC cultures (ex
HUVEC vs HAEC) we identified the cell line in which
these 3 miRNAs had higher expression. High miRNA
expression is associated with lower mRNA expression.
In 13 of our 15 comparisons (87%), the culture with
higher expressed miRNA had lower expression of genes
predicted to have that miRNA binding site.
Sylamer can also be used to identify the genes to
which miRNAs bind. We identified 51, 98 and 571
genes under the peaks for miR-99b, miR-20b and let-7b
respectively (Figure 3A). The number of genes is a fea-
ture of both the sequence motif and the peak width.
Known endothelial cell expressed putative targets of
miR-99b found under the peak include mechanistic tar-
get of rapamycin (MTOR), sonic hedgehog (SHH), man-
nin-binding lectin serine peptidase 1 (MASP1), and
forkhead box O3 (FOXO3). Putative targets of miR-20b
include polycystic kidney disease 2 (PKD2), matrix
metallopeptidase 3 (MMP3), syndecan 2 (SDC2)a n d
fibroblast growth factor receptor substrate 2 (FRS2). For
let-7b, potential targets include prostaglandin E receptor
3( PTGER3), toll-like receptor 4 (TLR4), kruppel-like
factor 2 (KLF2), and beta 3 integrin (ITGB3).
MiRNA diversity across endothelial, epithelial and
hematologic cells
We then sought to understand how EC miRNA expres-
sion related to expression in other cell lineages. We
used GEO to identify miRNA datasets generated using
Agilent V3 miRNA arrays and methods similar to our
own. We obtained data from 17 epithelial and 5 hema-
tologic type cells. Across endothelial, epithelial and
hematologic cells, 258 miRNAs were identified that
were expressed in at least one cell type. This represents
31% of the human miRNAs present on the Agilent V3
Table 1 Significant differences between EC types by
miRNA cluster groups
Cluster Comparison Z. score Adj. P. value
miR-512 HUVEC-HDMVEC -5.49 5.7E-05
HUVEC-HPAEC -5.23 2.4E-04
HUVEC-HCEC -5.13 4.0E-04
miR-379 HDMVEC-HBMVEC -7.76 1.2E-11
HUVEC-HDMVEC 6.79 1.5E-08
HCEC-HBMVEC -6.56 7.3E-08
HPAEC-HBMVEC -5.99 3.0E-06
HUVEC-HCEC 5.60 2.9E-05
HPMVEC-HDMVEC 5.23 2.3E-04
HUVEC-HPAEC 5.03 6.9E-04
miR-17 HUVEC-HPAEC 4.21 3.6E-02
miR-424 HPAEC-HDMVEC -4.53 8.2E-03
HUVEC-HPAEC 4.23 3.2E-02
HDMVEC-HCEC 4.18 4.0E-02
miR-99b HUVEC-HCEC -5.42 8.2E-05
HCEC-HBMVEC 5.07 5.6E-04
HPAEC-HDMVEC 4.58 6.5E-03
miR-106b HUVEC-HPAEC 4.19 3.9E-02
let-7a HUVEC-HDMVEC -5.11 4.4E-04
HDMVEC-HBMVEC 4.99 8.5E-04
HPAEC-HDMVEC -4.61 5.7E-03
miR-15b HPAEC-HDMVEC -4.25 2.9E-02
miR-512 cluster: miR-512, miR-1323, miR-498, miR-520e, miR-515, miR-519e,
miR-520f, miR-519c, miR-1283, miR-520a, miR-526b, miR-519b, miR-525, miR-
523, miR-518f, miR-520b, miR-518b, miR-520c, miR-518c, miR-524, miR-517a,
miR-519d, miR-521, miR-520d, miR-517b, miR-520g, miR-516b, miR-518e, miR-
518a, miR-518d, miR-516b, miR-517c, miR-520h, miR-521, miR-522, miR-516a,
miR-1283
miR-379 cluster: miR-379, miR-411, miR-299, miR-380, miR-1197, miR-323, miR-
758, miR-329, miR-494, miR-543, miR-495, miR-376c, miR-376a, miR-654, miR-
376b, miR-376a, miR-300, miR-1185, miR-381, miR-487b, miR-539, miR-889,
miR-544, miR-655, miR-487a, miR-382, miR-134, miR-668, miR-485, miR-323b,
miR-154, miR-496, miR-377, miR-541, miR-409-3p, miR-412, miR-369, miR-410,
miR-656
miR-17 cluster: miR-17, miR-18a, miR-19a, miR-20a, miR-19b, miR-92a
miR-424 cluster: miR-424, miR-503, miR-542, miR-450a, miR-450b, miR-450b
miR-99b cluster: miR-99b, let-7e, miR-125a
miR-106b cluster: miR-106b, miR-93, miR-25
let-7a cluster: let-7a, let-7b
miR-15b cluster: miR-15b, miR-16
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Page 4 of 13miRNA array. There was marked diversity of miRNA
expression resulting in a clear separation of these three
different lineages (Figure 4A). Of the expressed miR-
NAs, 98 miRNAs (38%) were expressed in all cell types
(Figure 4B, Additional file 4, Table S2). Thirty-one miR-
NAs were unique to ECs and an additional 33 were
shared with either hematologic or epithelial cells, but
not both. Representative heat maps of these different
cell comparisons demonstrate these differences (Figure
4C). We also generated a Venn diagram based on
LIMMA pairwise comparisons of the 3 cell lineages.
This second Venn diagram only investigated miRNAs
that were statistically different between at least two cell
lineages. Thirty miRNAs, such as miR-126, had expres-
sion levels that varied across all 3 cell lineages (Addi-
tional file 5 Figure S3, Figure 4D).
Finally we again wanted to determine if the differences
in miRNA expression were explained primarily at the
level of transcription. Thus we used the miRNA chro-
mosomal cluster data and identified all clusters that had
at least one LIMMA significant difference between cell
lineages. Of these 23 clusters, all but 3 (87%) show
strong consistent expression across a chromosomal clus-
ter for a given cell type (Figure 5).
RT-PCR confirmation of 3 cell lineage miRNA array data
We used RT-PCR to validate the array data results
across cell types. RT-PCR was performed using a repre-
sentative EC line (HAEC), epithelial cell line (pancreatic
ductal epithelium) and hematologic cells (peripheral
blood mononuclear cells). We performed RT-PCR on 6
miRNAs that were found to be dramatically, or subtly
variable amongst the three cell lineages. We identified
clear validation of the in silico results particularly for
miRNAs miR-126, miR-141 and miR-142-3p (Figure 4D,
Additional file 6, Figure S4).
Discussion
This is the first study to investigate baseline miRNA
diversity in ECs and compare the EC miRNA expression
pattern to other major cell types. Using the deep Agilent
V3 miRNA array, we found 164 miRNAs expressed in
Figure 2 LNA-ISH of miRNAs miR-126, let-7b and U6 snRNA. PECAM1 (CD31) staining of endothelial cells. (A-D) Human skin including
epidermis, (E-H) human lung, (I-L) coronary artery, (M-P) human brain and (Q-T) human umbilical vein. * represents the location of ECs. For LNA-
ISH, positive staining is blue. For PECAM1 IHC, positive staining is brown. Original magnification 160× (A-H, M-T) or 100× (I-L).
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Page 5 of 13ECs. The vast majority of these miRNAs have similar
expression patterns. Given the extent of the similarity,
miRNA studies in one EC type (ex HUVEC) should be
generally applicable to all EC types. However, we were
able to identify three miRNAs, miR-99b, miR-20b and
let-7b, which were modestly, but significantly variable
among the EC lines by three different types of analysis:
LIMMA, SAM and Sylamer analysis. These clustered
the EC types into three discrete groups (Figure 1B).
Our data set adds to the understanding of the pre-
viously described tissue-wide miRNA studies. For
example, miR-126 had relatively high expression in
the heart, spleen and thymus and lower expression in
the pancreas, colon and fallopian tubes [5]. This cor-
relates with the known relative vascularity of these
organs.
Essentially all miRNAs that have previously been
described in ECs were in our dataset [19-21]. However,
a few were not represented. These miRNAs are gener-
ally described as being upregulated by various external
stimuli which were not used in this study. This includes
miR-663 which is upregulated by shear stress [22] and
miR-200c, which is upregulated by oxidative stress [23].
Of the 31 “EC only” miRNAs in our data set, more than
half have not previously been identified in ECs and
represent new targets for evaluation.
We used our miRNA data to determine if certain
types of ECs clustered together. MicroRNA-based clus-
tering has been shown to be a stronger classifier of can-
cer cell samples than mRNA clustering [24]. We
predicted a priori that ECs would cluster into macrovas-
cular and microvascular groups. However, the clustering
pattern was more complicated. HPAECs and HCECs
clustered together, similar to the previously reported
mRNA data [16]. HAECs did not cluster with the
HPAECs or HCECs, but instead clustered with the
microvascular cell cultures HDMVECs and HPMVECs.
This was interesting as our HCECs and HAECs were
taken from the same individual. We interpret this as evi-
dence that inherited variation is less important to
miRNA expression levels than acquired changes based
on the vascular location of the ECs. We found that
HUVEC and HBMVECs clustered tightly, which was
unexpected. We entertained cell passage, the age of the
cell donor, and cell confluence as causes of clustering
[25-27]. Each was ruled out. The HDMVECs and
HUVECs were of fetal origin, the HAECs and HCECs
were taken from a young child and the donor’sa g eo f
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Figure 4 Endothelial, epithelial and hematologic cell comparisons. (A) Cluster analysis of endothelial, epithelial and hematologic cells from
the same miRNA expression platform based on LIMMA analysis. (B) Venn diagram indicating the complete unique and shared expression
patterns of miRNAs between endothelial, epithelial and heamtologic cell types. (C) Representative heat maps from 6 areas of the Venn diagram
identifying specific miRNAs in different colored areas. A complete distribution of all miRNA expression is found in the Additional file 4, Table S2.
(D) RT-PCR validation of variable expression between cell lines for miRNAs miR-126, miR-141 and miR-142-3p. The left image is a histogram of
the frequency of expression from the GEO data set. Epithelial cell lines are red, ECs are blue and hematologic lines are black. The right image is
RT-PCR data of the same miRNAs normalized to U6 snRNA.
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Page 7 of 13the other commercially obtained cell cultures is
unknown. All cells were used within passages 3-6.
Finally, although all ECs were grown under the exact
same conditions, some EC cultures grew faster than
others affecting confluency at harvesting (~85-95%).
Although some miRNAs are upregulated at higher con-
fluence, miRNAs miR-20b, miR-99b and let-7b have not
been shown to be modulated by this effect, and further-
m o r e ,t h e r ew a sn oc o n s i s t e n tp a t t e r no fas i n g l eE C
line, overexpressing a variety of miRNAs [27].
We provided two sets of data that support the tran-
scriptional polycistronic regulation of miRNAs [5]. First,
among the ECs, the chromosomal clusters for miRNAs,
let-7b, miR-20b and miR-99b all had relative expression
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Figure 5 Heat maps of 23 polycistronic chromosome miRNA clusters. Each chromosome cluster was selected based on having at least one
LIMMA significant pairwise difference. Twenty of 23 chromosome clusters generally display consistent, differential expression between
endothelial, epithelial and hematologic cells.
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Page 8 of 13patterns that were consistent and supported by RT-PCR
of primary transcripts for two clusters (Figure 1C, Addi-
tional file 2, Figure S1). Second, the polycistronic miR-
NAs that varied between endothelial, epithelial and
hematologic cells, were almost exclusively (87%) similar
in expression patterns for adjacent miRNAs (Figure 5).
There is only limited information on the role of miR-
NAs let-7b, miR-20b and miR-99b in ECs, although this
information is intriguing. MiR-20b is known to regulate
estrogen receptor a (ERa), nuclear receptor coactivator
3( NCOA3/AIB1) and hypoxia inducible factor 1a
(HIF1a) [28,29]. It is also decreased in hypoxia [30].
Let-7b regulates tissue inhibitor of matrix metalloprotei-
nase 1 (TIMP1) which has anti-angiogenic properties
[31]. It also regulates high mobility group at-hook
(HMGA2), nuclear receptor subfamily 2, group E, mem-
ber 1 (NR2E1/TLX), cyclin D1 (CCND1)a n di s
increased in skeletal muscle of older individuals [32-35].
Higher expression of miR-99b is associated with lymph
node metastases in esophageal adenocarcinoma [36].
The miR-99b, let-7e, miR-125 cluster modulates
HMGA2 and SWI/SNF-related, matrix-associated, actin-
dependent regulator of chromatin, subfamily A, member
5( SMARCA5) [37].
Our use of Sylamer was novel in a way that bears dis-
cussion. Sylamer has traditionally been used in the setting
of a specific miRNA knockdown or overexpression to
evaluate a targeted set of genes. Reasoning that global
changes in mRNA expression would result in miRNA dif-
ferences, we tested whether Sylamer could be used in a
new manner to predict differentially expressed miRNAs.
In our experiment there was no overwhelmingly signifi-
cant p value for a miRNA signature [38]. Rather, sifting
through smaller, more frequent changes, we found
numerous minor effects. We used the summation of the
data to demonstrate a clear increase in miRNA binding
sites for let-7b, miR-20b and miR-99b in genes that were
variably expressed across EC types in this additional data
set. This information, along with the RT-PCR data, help
confirm the uniqueness of these 3 miRNAs. Also, most
of the peaks we identified for miRNAs miR-99b, miR-20b
and let-7b were not at the extreme edge of the graph
(Figure 3). This signifies that the most extremely altered
genes, are not regulated directly by these miRNAs. Rather
they may be downstream of pathways regulated by miR-
NAs or other regulatory activities in the cell.
We have for the first time established the miRNA
expression pattern of ECs relative to epithelial and
hematologic cells. Not surprisingly, there were many dif-
ferences between these cell types. This data will help
identify those miRNAs whose activities may regulate
functions more intrinsic to one or the other types of
cells. It may also assist in determining the origin of
miRNAs found in serum [39].
There were a number of limitations to our study. In
our comparison of ECs to other cell types, we were lim-
ited by the available matching data (same array, same
processing software) in GEO. Despite careful sample
preparation, processing, and analysis, it is possible that
some of the microarray results were affected by techni-
cal artifacts introduced by the sample selection, microar-
ray platform, or the hybridization procedure. We
addressed this possibility by using two complementary
technologies (RT-PCR and Sylamer) to provide further
evidence supporting our findings; however, independent
replication of the results reported here using different
samples and/or a different microarray platform would
certainly provide further evidence. The limited amount
of publicly available Agilent V3 miRNA microarray data
precluded us from generating Gene Expression Bar-
codes, a more robust method to assess absolute expres-
sion [26]. Also, because we only had 3 cell types to
compare, it is likely some of the “cell specific” miRNAs
can be found in other cell types not contained in our
analysis. In our Sylamer data, because multiple miRNAs
can bind to the same consensus sequence, the data we
present for miR-20b, miR-99b and let-7b could be data
for other related miRNAs such as miR-17, miR-100 or
another let-7 miRNA.
The expression and relative levels of the EC miRNAs
are likely influenced by the choice of matrix material
(gelatin), culture media, and lack of other external fac-
tors (shear stress, etc) in our experimental design. In an
in vivo setting, with different extracellular matrices,
paracrine signals from adjacent cells, shear stress and
other factors, the miRNA expression would be expected
to vary from this controlled environment. Thus the gen-
eralizability of our findings awaits further study.
Conclusions
Our study fills a critical need in the developing EC
miRNA story. We have, for the first time, fully charac-
terized and catalogued baseline EC miRNA expression
from multiple EC locations. We show high similarity
between ECs and great diversity between endothelial,
epithelial and hematologic cells. We identify three miR-
NAs (miR-20b, miR-99b and let-7b) that may confer
some of the unique phenotypic diversity to ECs and are
worthy of further evaluation.
Methods
Human primary endothelial cell sources
HAEC and HCEC were harvested from a human aorta
and coronary artery taken during cardiac transplantation
of a 7-year-old girl. Cells were purified by CD31 mag-
netic bead separation (Dynal, Carlsbad, CA) and con-
firmed for EC phenotype by DiI-Ac-LDL staining and
CD31 flow cytometry (Additional file 7, Figure S5).
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logics, Invitrogen cell culture (Invitrogen, Carlsbad, CA).
HBMVECs, HUVECs, HPAECs and HPMVECs were
purchased from ScienCell Research Laboratories (Scien-
Cell, Carlsbad, CA).
Human primary endothelial cells culture
Human primary endothelial cells were grown on a 2%
gelatin matrix with Endothelial Cell Medium (ECM,
ScienCell, Carlsbad, CA) supplemented with ECGS
(ScienCell, Carlsbad, CA) and 5% FBS (ScienCell, Carls-
bad, CA). Cells were grown to 75% confluence, at which
time, the media was changed and cells were harvested
for RNA 24 hours later, when confluence was ~95%. All
cells were between passages 3-6 for these experiments.
Agilent V3 miRNA array
Total RNA was isolated by miRNeasy kit (QIAGEN,
Valencia, CA) according to the manufacturer’si n s t r u c -
tions. RNA quality was assessed using a Bioanalyser
(Agilent, Santa Clara CA). All samples achieved an RNA
integrity number (RIN) score greater than 9.5 [40]. RNA
samples were then run in duplicate on an Agilent V3
miRNA array according to the manufacturer’si n s t r u c -
tions in the JHMI Microarray Core Facility. Raw Agilent
V 3m i R N Ad a t aw e r ep r e p r o c e s s e du s i n gam o d i f i e d
version of Robust Multi-array Analysis (RMA)[41] with-
out background correction, implemented in the AgiMi-
croRna R package [42]. This preprocessing method has
been shown to have better precision than the preproces-
sing method recommended by Agilent [43]. The array
data has been submitted to GEO (GSE30512).
miRNA RT-PCR
Total RNA was isolated from human primary endothe-
lial cells, epithelial HPNE cells, and hematologic cells
using TRIzol reagents (Invitrogen, Carlsbad, CA) follow-
ing manufacturer’s instructions. RT-PCR was performed
with TaqMan
® microRNA assays (Applied Biosystems)
following the manufacturer’s protocol. The thermal
cycler’s program for reverse transcription was 16°C for
30 minutes, 42°C for 30 minutes and 85°C for 5 minutes
followed by 4°C hold. The amplification protocol was
95°C for 10 minutes, 95°C for 15 seconds and anneal/
extend at 60°C for 60 seconds, total cycle number is 40.
Expression levels were normalized to U6 snRNA by
ΔΔCt methods.
qPCR
For measuring expression of the miR-99b and let-7a pri-
mary transcripts, cDNAs were created from total RNA
using the QuantiTect reverse transcript kit (Qiagen) fol-
lowing the manufacturers protocol. qPCR was per-
formed using the SYBR Green PCR master mix (Applied
Biosystems). Transcript abundance was normalized to b-
actin expression. Primer sequences for miR-99b cluster
(FW: GCCTGTCTCCTCTGCTTCAC; RV: AGGCCT
CCTCACACTCTTCA) and let-7a cluster (FW: CCTGA
GCAGGAAGTGAGAGG; RV: CCTCAGTTTCCC-
CAGGTACA) were designed to amplify a region found
within an exon in the annotated Refseq gene proximal
to the miRNAs.
Database mining
Gene Expression Omnibus (GEO, http://www.ncbi.nlm.
nih.gov/geo/) was searched for miRNA array datasets
that were performed on the Agilent V3 miRNA chip set
and analyzed with Agilent software. Sixty-one samples
from 4 experiments (GSE22380, GSE25435, GSE23815,
GSE24222) were identified of which 22 were “control”
or “untreated samples.” These 22 samples were from
peripheral blood mononuclear cells (PBMCs), CD34+
bone marrow cells, bladder epithelial cells, LNCap cells,
and the bladder cancer cell line EJ. All raw data sets
were preprocessed using the same method [42].
MiRNA clusters were identified by performing a
search at miRBase http://www.mirbase.org for clusters
with an inter-miRNA distance of 10, 000 kb. Sixty-six
clusters, relevant to the miRNAs present on the Agilent
V3 chip, were identified.
EC mRNA dataset GSE21212 was obtained from GEO
and normalized using the RMA method in R.
Venn diagram construction
Two types of Venn diagrams were generated to demon-
strate diversity across the different cell types. One Venn
diagram was generated by hand curating the normalized
expression data of each sample and validating this with
deep RNA sequencing reports [44,45] and northern blot
images culled from the literature. A second type was
generated by identifying miRNAs that were differentially
expressed between cell types based on a moderated t-
test [46].
Sylamer analysis
Sylamer was used to analyze miRNA binding site differ-
ences in 3’UTR regions of human genes [18]. The analy-
sis was performed using EC mRNA data from the
GSE21212 dataset [16]. Average expression levels of 44,
792 gene probes from each cell type (ex. HUVEC,
H A E C )w e r ec o m p a r e db e t w e e ns a m p l e sa n dr a n k
ordered by relative expression differences. All EC types
were paired (HAEC, HCEC, HDMVEC, HPAEC,
HUVEC) in 11 comparisons. The rank ordered probe
sets were uploaded into SylArray and analysis was per-
formed against Affymetrix HG_U133_Plus_2 identifiers
to maximize the number of genes queried. Statistical
significance was assessed using hypergeometric test
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-4 to identify miR-
NAs whose 3’UTR binding signatures were elevated in
any comparison. After all significant miRNAs were iden-
tified across 11 comparisons, a resampling analysis was
performed. Here, the total number of significant enrich-
ments for the miRNAs miR-20b, miR-99b and let-7b
were compared to all other significant enrichments of
the other 527 miRNA 3’UTR binding sites. A histogram
of the number of significant observations in 10, 000 ran-
dom assignments of 3 miRNAs was generated to
demonstrate the significance of the observed result. The
identification of putative 3’ UTRs bound by these miR-
NAs was made by identifying the genes under the peak
of each miRNA at the cutoff of ≤10
-4.T h e3 ’ UTR
miRNA binding site for miR-20b is GCACTTTG and is
shared with miR-17. The 3’ UTR miRNA binding site
for let-7b is CTACCTCA and is shared with let-7a-i and
miR-98. The 3’ UTR miRNA binding site for miR-99b is
TACGGGTT and is shared with miR-99a and miR-100.
LNA-ISH and IHC
Locked nucleic acid - In situ hybridization was performed
using the protocol of Jǿrgensen et al with modifications
as described below [47]. Cases were obtained of lung,
coronary artery, placenta, brain, and skin from the surgi-
cal pathology files of The Johns Hopkins Hospital.
Unstained slides were cut from tissue blocks using RNA
precautions. An 8 minute pepsin digest at 37°C (Dako,
Denmark) in place of proteinase-K treatment was per-
formed on the slides prior to hybridization. A VWR slide
warmer was used instead of a Dako hybridizer for the in
situ hybridization step. Levamisole (Dako) was used to
inhibit endogenous alkaline phosphatase. Counterstain
was performed with 50% eosin (Richard-Allen, Kalama-
zoo, MI). Double digoxigenin (DIG)-labeled miRCURY
LNA detection probes for miR-126, let-7b and U6
snRNA (Exiqon A/S, Denmark) were used.
PECAM1 (CD31) immunohistochemistry was per-
formed using standard IHC protocols. Briefly, 6 micron
slides underwent high-temperature antigen retrieval and
paraffin removal in Trilogy solution (Cell Marque, Hot
Springs, AR) in a pressure cooker. Endogenous peroxi-
dase activity was blocked and slides were incubated with
a goat primary PECAM-1 antibody (Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA) at 1:100 for 30 minutes.
Then slides were incubated with a goat HRP polymer
conjugate (SuperPicTure, Invitrogen, Camarillo, CA) for
10 minutes, stained with Impact DAB (Vector Labs,
Burlingame, CA) for 3 minutes then counterstained with
hematoxylin (Richard-Allen Scientific, Kalamazoo, MI).
Statistical analysis
Differential expression was assessed using two methods:
Significance Analysis of Microarrays (SAM) [48] and
LIMMA [46]. Pearson’sp a i r w i s ec o r r e l a t i o nw a su s e d
on the normalized values of miRNAs performed in
duplicate to determine the relationship between miR-
NAs within the same chromosome cluster.
Additional material
Additional file 1: Additional table S1. LIMMA pairwise differential
expression analysis.
Additional file 2: Additional figure S1. RT-PCR data results for miR-20b,
miR-99b and let-7b and pri-miRNA cluster data for let-7a and miR-99
clusters. The miRNA data is normalized to U6 snRNA and the pri-miRNA
is normalized to b-actin. Significant differences between each EC
comparison are reported in Additional file 1, Table S1.
Additional file 3: Additional figure S2. miR-126 (A) LNA-ISH staining
for miR-126 in a lymph node. The endothelial cell staining (arrows) is
much stronger than the background hematopoietic cells.
Additional file 4: Additional table S2. miRNA expression patterns in
endothelial, epithelial and hematologic cells.
Additional file 5: Additional figure S3. Venn diagram displaying the
overlap of differentially expressed miRNAs based on LIMMA pairwise
comparisons. Twenty-three miRNAs have expression levels that can
discriminate between the three cell types (ex miR-126 as seen in Figure
4D). Thirty-two miRNAs differ between endothelial cells and the other
two cell types, thirty-eight miRNAs differ between hematologic cells and
the others, and 13 differ between epithelial and the others. Fifty (34+9
+7) were differentially expressed in only one comparison, and ninety-
nine were not differentially expressed in any of the three comparisons.
Additional file 6: Additional figure S4. RT-PCR validation of variable
expression between cell lines. The left image is a histogram of the
frequency of expression from the GEO data set. Epithelial cell lines are
red, ECs are blue and hematologic lines are dark yellow. The normalized
RT-PCR data of three additional miRNAs (miR-432, miR-210 and miR-186)
are seen to the right, sharing the same color scheme as the histograms.
The RT-PCR data generally supports the in silico results based on
normalized GEO dataset values.
Additional file 7: Additional figure S5. Flow cytometry results for
HAECs and HCECs after 4 passages. Flow cytometry for CD31 (PECAM-1)
was performed. The blue peak is for CD31 and the red peak is for an
isotype control. For HAECs, 99.67% of cells were CD31+ and for HCECs,
97.52% were CD31+.
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